NCT00154414
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
155 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00318422
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Córdoba, Argentina
Completed
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Århus C, Denmark
Completed
Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes
NCT02252965
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Please contact the Merck KGaA Communication Center Darmstadt, Germany
NCT01508806
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Christchurch, Australia
NCT01620463
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Completed
Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
NCT01509755
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Århus C, Denmark
- Novo Nordisk Investigational Site Copenhagen, Denmark
- Novo Nordisk Investigational Site Hvidovre, Denmark
- Novo Nordisk Investigational Site Kolding, Denmark
NCT01507311
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Århus C, Denmark
NCT01508858
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Uppsala, Sweden
Completed
The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin
NCT01043510
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Chula Vista, California, United States